Barely Significant
← all excerpts

Recombinant BCG-Ag85A enhances antitumor immunity and controls melanoma progression through multimodal immune activation in mice.

Arch Microbiol · 2026 · PMC13442610 · PMID 42554758

Europe PMCDOI
1
hedged sentence
0.0500
closest p · 1.0× alpha
0.0500
boldest claim

The sentences

highly significantp < 0.05actually significant
In contrast, animals treated with rBCG- Ag85A exhibited a highly significant restriction in tumor growth, maintaining a mean tumor volume of 249.43 mm 3 at the same timepoint (p < 0.05; Fig. 7 A).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.